Tower Research Capital LLC (Trc) Olema Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,394 shares of OLMA stock, worth $26,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,394
Previous 22,714
76.25%
Holding current value
$26,160
Previous $132,000
84.85%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding OLMA
# of Institutions
135Shares Held
64.3MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$33.2 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$32.7 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$25.7 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$16.7 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $196M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...